Heal House Vitiligo Research 12 · Letter
Do organ transplant recipients on immunosuppressants develop less vitiligo?
Decreased risk of vitiligo in organ transplant recipients: A population-based cohort study
Last reviewed
In short
New-onset vitiligo was less common in people taking immunosuppressants after organ transplantation. This supports the understanding that vitiligo is an immune-related condition.
If vitiligo is truly a disease of the 'immune system,' then it would make sense that people receiving treatment to suppress the immune system would develop less vitiligo. Organ transplant recipients take immunosuppressants for a long time to prevent rejection. I thought these individuals would be a good clue to test that question. So, using nationwide data, I compared the occurrence of vitiligo between those who received transplants and those who did not.
Q1 Why is it significant that organ transplant patients develop vitiligo less often?
Organ transplant recipients had a lower rate of new-onset vitiligo. This supports that vitiligo is a disease deeply intertwined with the immune system. Transplant recipients consistently take immunosuppressive medications to prevent rejection. The fact that vitiligo occurred less in this immune-suppressed environment aligns well with the explanation that 'excessive immune activity attacks pigment cells, causing vitiligo.' Conversely, it hints that modulating the direction of the immune response could be a key to managing vitiligo. This is also connected to the reason why immune-modulating drugs are used in vitiligo treatment. However, this is a trend observed in large-scale data. You should not misunderstand immunosuppressants as a preventive medication for vitiligo.
Closing remarks
This study indirectly examined why vitiligo occurs by looking at data from people who received other treatments. The finding that suppressing the immune system led to less vitiligo adds a piece to the larger picture that the root of vitiligo lies in an excessive immune response. I hope that such evidence will eventually lead to vitiligo treatments that precisely balance the immune system.
